SILVER SPRING, Md., Aug. 15, 2011 /PRNewswire-USNewswire/ -- Science, public health, and regulatory highlights from the U.S. Food and Drug Administration. Information in this document is designed for credentialed journalists. Release dates and times for items are current as of August 15, 2011.
FDA News & Notes does not contain any regulatory or enforcement actions due to legal limitations.
(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO )
Meetings, Workshops and Congressional Testimony:
Tuesday, 8/16 – The FDA Risk Communication Advisory Committee presents "Communicating Risks and Benefits: An Evidence-Based User's Guide," compiled by current and former members of the Advisory Committee. 8 a.m., 10903 New Hampshire Ave., Building 31, Room 1503, Silver Spring, Md.
Press Office Contact: Morgan Liscinsky, 301-796-0397, [email protected]
On the Web:
Guidance for Industry and Food and Drug Administration Staff - Class II Special Controls Guidance Document: Herpes Simplex Virus Types 1 and 2 Serological Assays Guidance issued with a Federal Register final rule.
Press Office Contact: Erica Jefferson, 301-796-4988, [email protected]
Public Workshop Announcement: Mobile Medical Applications Draft Guidance. A two-day forum beginning 9/12 for discussion and public comment on the Mobile Medical Applications draft guidance.
Press Office Contact: Erica Jefferson, 301-796-4988, [email protected]
FDA Office of Public Affairs Contact Information:
Call or email FDA Office of Public Affairs, 301-796-4540, [email protected]
List of FDA press officers and beats
More Resources:
FDA News and Events
FDA Photos (Flickr)
Consumer Health Information
CONTACT: Raymond Formanek Jr. 301-796-4677
SOURCE U.S. Food and Drug Administration
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article